Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Dose Ranging Study of Hexadecasaccharide Including Active Control, in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction Scheduled to Undergo Percutaneous Coronary Intervention (SHINE)

NCT00123565 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00123565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00123565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Dose Ranging Study of Hexadecasaccharide Including Active Control, in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction Scheduled to Undergo Percutaneous Coronary Intervention (SHINE)
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2004
Completion date
May 31, 2007
Enrollment
1,257 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

coronary atherosclerosis